A powder based on morin, a natural compound extracted from plants such as guava leaves, apple and fig peels, certain teas, and almonds, has shown antimicrobial, anti-inflammatory, and antioxidant effects against bacteria that cause periodontal disease.
Researchers have developed a generative AI model that uses large-scale health records to estimate how human health may change over time. It can forecast the risk and timing of over 1,000 diseases and predict health outcomes over a decade in advance.
A newly developed molecule brings together two powerful immunotherapy strategies in one treatment. Researchers at the University of Basel and University Hospital Basel, Switzerland, have demonstrated that this fusion protein can both block the “do not attack” signal used by cancer cells and selectively activate tumor-fighting immune cells.
What if your smart watch could sense when you’re about to raid the fridge, and gently steer you toward a healthier choice instead?
This manufacturing site in Richmond, Virginia, is the first of four projects that Eli Lilly plans to reveal this year as part of a $27 billion U.S. investment announced earlier this year.
Jupiter Endovascular announced today that its Vertex catheter received FDA 510(k) clearance for the insertion of endovascular devices.
KENNESAW, Ga., Sept. 17, 2025 /PRNewswire/ — Dornier MedTech America (DMTA) has announced the full U.S. commercial launch of its Dornier Hoover Flexible and Navigable Suction Ureteral Access Sheath (FANS) and Dornier Axis II Slim single-use ureteroscope with a 5.6Fr. distal tip.
Durham, NC — September 16, 2025 — SutureTech, a surgeon-founded medical device company focused on advancing soft tissue and tendon repair, today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for RapidFix™, its flagship device.
The Moberg Clinical Platform brings advanced analytics and AI to critical care, offering clinicians new insights into brain function that can directly inform patient management
WALTHAM, Mass., Sept. 16, 2025 /PRNewswire/ — Body Vision Medical, a global leader in AI-powered intraoperative imaging, is proud to announce that its LungVision AI-powered advanced imaging system has received regulatory approval from the Central Drugs Standard Control Organization (CDSCO) in India. This approval marks a significant milestone in the company’s mission to improve early and accurate lung cancer diagnosis worldwide.